{"id":"https://openalex.org/W2249641340","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4556","title":"A randomized phase II and coagulation study of bevacizumab alone or with docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma","display_name":"A randomized phase II and coagulation study of bevacizumab alone or with docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2249641340","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4556","mag":"2249641340"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.4556","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.4556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087332592","display_name":"Igor A. Astsaturov","orcid":"https://orcid.org/0000-0002-8613-1890","observed_orcids":["https://orcid.org/0000-0002-8613-1890"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. A. Astsaturov","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053128814","display_name":"Neal J. Meropol","orcid":"https://orcid.org/0000-0001-6353-7364","observed_orcids":["https://orcid.org/0000-0001-6353-7364"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. J. Meropol","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049901305","display_name":"R. Katherine Alpaugh","orcid":"https://orcid.org/0000-0002-6775-5323","observed_orcids":["https://orcid.org/0000-0002-6775-5323"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. K. Alpaugh","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089998052","display_name":"J. D. Cheng","orcid":"https://orcid.org/0009-0003-6555-1591","observed_orcids":["https://orcid.org/0009-0003-6555-1591"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. D. Cheng","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085559355","display_name":"Nancy L. Lewis","orcid":"https://orcid.org/0000-0002-6710-6999","observed_orcids":["https://orcid.org/0000-0002-6710-6999"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. L. Lewis","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033270447","display_name":"Mary Beard","orcid":"https://orcid.org/0000-0001-7058-576X","observed_orcids":["https://orcid.org/0000-0001-7058-576X"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Beard","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090472587","display_name":"Andr\u00e9 Rogatko","orcid":"https://orcid.org/0000-0001-8935-8890","observed_orcids":["https://orcid.org/0000-0001-8935-8890"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Rogatko","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021223600","display_name":"Zhiheng Xu","orcid":"https://orcid.org/0000-0002-4809-2851","observed_orcids":["https://orcid.org/0000-0002-4809-2851","https://orcid.org/0009-0008-0751-5548"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Z. Xu","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045107557","display_name":"Louis M. Weiner","orcid":"https://orcid.org/0000-0001-5192-0710","observed_orcids":["https://orcid.org/0000-0001-5192-0710"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. M. Weiner","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103737583","display_name":"Steven J. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. J. Cohen","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA; Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I1289437631","https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"4556","last_page":"4556"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":1.0},{"id":"https://openalex.org/keywords/metastatic-pancreatic-adenocarcinoma","display_name":"metastatic pancreatic adenocarcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.7730000019073486},{"id":"https://openalex.org/keywords/blood-coagulation","display_name":"coagulation","score":0.796999990940094},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8240000009536743},{"id":"https://openalex.org/keywords/basic-fibroblast-growth-factor","display_name":"basic fibroblast growth factor","score":0.8629999756813049},{"id":"https://openalex.org/keywords/circulating-endothelial-cells","display_name":"circulating endothelial cells","score":0.9079999923706055},{"id":"https://openalex.org/keywords/thrombin-antithrombin-complex","display_name":"thrombin-antithrombin complex","score":0.9539999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8870000243186951},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5569999814033508},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5019999742507935},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.7049999833106995},{"id":"https://openalex.org/keywords/intestinal-perforation","display_name":"intestinal perforation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/two-stage-design","display_name":"two-stage design","score":0.5789999961853027},{"id":"https://openalex.org/keywords/early-stopping","display_name":"early stopping","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.941206693649292},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.74284827709198},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6505993008613586},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6193201541900635},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6189790368080139},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5684406161308289},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5639373660087585},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5282891392707825},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5143662691116333},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4505409300327301},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4494485557079315},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3736265003681183},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29604771733283997},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28827160596847534},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.22965246438980103}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.4556","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.4556","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.4556","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7799999713897705}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990622503","https://openalex.org/W2124863710","https://openalex.org/W2084555154","https://openalex.org/W2243193473","https://openalex.org/W2094037194","https://openalex.org/W2240529528","https://openalex.org/W2590893558","https://openalex.org/W3010703934","https://openalex.org/W2026107878","https://openalex.org/W2078765033"],"abstract_inverted_index":{"4556":[0],"Background:":[1],"Vascular":[2],"endothelial":[3,136],"growth":[4,130],"factor":[5,131,307],"(VEGF)":[6],"is":[7],"overexpressed":[8],"in":[9,34,150,190,195,227,240,252,260,348],"pancreatic":[10,41,350],"cancer":[11],"and":[12,48,64,93,117,134,153,193,212,230,236,245,249,255,257,291,308,319,326,355,364,367],"interacts":[13],"with":[14,31,37,50,81,112,142,224,233,302,315,335,342],"coagulation":[15,126,356],"to":[16,43],"promote":[17],"angiogenesis.":[18],"We":[19],"performed":[20],"this":[21],"randomized":[22],"phase":[23],"II":[24],"study":[25,270],"of":[26,147,169,281],"bevacizumab":[27],"(BEV)":[28],"alone":[29,77,340],"or":[30,80,341],"docetaxel":[32],"(DOC)":[33],"patients":[35],"(pts)":[36],"previously":[38],"treated":[39],"metastatic":[40],"adenocarcinoma":[42],"investigate":[44],"their":[45],"clinical":[46,336],"activity":[47,347],"interaction":[49],"coagulation.":[51],"Methods:":[52],"Eligible":[53],"pts":[54,162,189,223,232,276],"had":[55,198,279],"one":[56,237],"prior":[57],"gemcitabine":[58],"regimen,":[59],"PS":[60],"0\u20131,":[61],"measurable":[62],"disease,":[63],"no":[65],"bleeding/thrombosis.":[66],"BEV":[67,339],"was":[68,108,123,158,221,271],"given":[69],"at":[70,85,328],"10":[71],"mg/kg":[72],"IV":[73,88],"Q":[74,95],"2":[75,103,213],"weeks":[76],"(Arm":[78,83],"A)":[79],"DOC":[82,343],"B)":[84,211],"35":[86],"mg/m2":[87],"on":[89,296,311],"days":[90,251,259],"1,":[91],"8,":[92],"15":[94],"28":[96],"days.":[97],"CT":[98],"scans":[99],"were":[100,205,247,300,313,332],"obtained":[101,124],"every":[102],"cycles.":[104],"The":[105,269],"primary":[106],"endpoint":[107],"progression-free":[109],"survival":[110,119],"(PFS),":[111],"secondary":[113],"endpoints":[114],"response":[115],"rate":[116],"overall":[118],"(OS).":[120],"Peripheral":[121],"blood":[122],"for":[125,156,264,267,361],"parameters,":[127],"basic":[128],"fibroblast":[129],"(bFGF),":[132],"VEGF,":[133],"circulating":[135],"cells":[137],"(CEC).":[138],"A":[139,192,229,254],"two-stage":[140],"design":[141],"a":[143],"target":[144],"median":[145,174,180],"PFS":[146,244,280],"=4":[148,282],"months":[149],"either":[151],"arm":[152,278],"early":[154],"stopping":[155],"futility":[157],"utilized.":[159],"Results:":[160],"Thirty":[161],"(15":[163],"per":[164,172,217,277],"arm)":[165],"received":[166],"88":[167],"cycles":[168],"therapy":[170,359],"(44":[171],"arm,":[173],"2,":[175],"range":[176],"<1\u201310).":[177],"Pt":[178],"characteristics:":[179],"age":[181],"61.5":[182],"(range":[183],"38\u201381),":[184],"ECOG":[185],"0/1":[186],"(11/19).":[187],"Seven":[188],"Arm":[191,196,228,241,253,261],"8":[194],"B":[197,262],"grade":[199],"3/4":[200],"events.":[201],"Serious":[202],"adverse":[203],"events":[204],"5":[206,231],"DVT/PE":[207],"(3-Arm":[208],"A;":[209],"2-Arm":[210],"bowel":[214],"perforations":[215],"(1":[216],"arm).":[218],"Best":[219],"reponse":[220],"4":[222],"stable":[225,234],"disease":[226,235],"unconfirmed":[238],"PR":[239],"B.":[242],"Median":[243],"OS":[246,363],"43":[248],"181":[250],"45":[256],"123":[258],"(p=0.5":[263],"PFS,":[265],"p=0.8":[266],"OS).":[268],"stopped":[272],"after":[273],"only":[274],"2/15":[275],"months.":[283],"In":[284],"multivariate":[285],"analysis,":[286],"higher":[287],"bFGF":[288,354],"(HR=1.4,":[289],"p=0.008)":[290],"thrombin/antithrombin":[292],"complex":[293],"(TAT)":[294],"levels":[295,310,325],"treatment":[297],"(HR=1.75,":[298],"p<0.001)":[299],"associated":[301,314,334],"worse":[303,362],"OS.":[304],"D-dimer,":[305],"tissue":[306],"TAT":[309],"d15":[312],"increased":[316,365],"venous":[317],"thrombosis":[318],"GI":[320],"perforation":[321,366],"(p=0.04).":[322],"VEGF":[323],"plasma":[324,353],"CEC":[327],"all":[329],"time":[330],"points":[331],"not":[333],"outcomes.":[337],"Conclusions:":[338],"has":[344],"minimal":[345],"antitumor":[346],"gemcitabine-refractory":[349],"cancer.":[351],"Increased":[352],"markers":[357],"during":[358],"predict":[360],"thrombosis.":[368],"[Table:":[369],"see":[370],"text]":[371]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}